Annual Total Expenses
$13.18 B
+$530.00 M+4.19%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual total expenses is $13.18 billion, with the most recent change of +$530.00 million (+4.19%) on December 31, 2024.
- During the last 3 years, TEVA annual total expenses has risen by +$402.00 million (+3.15%).
- TEVA annual total expenses is now -26.20% below its all-time high of $17.86 billion, reached on December 31, 2017.
Performance
TEVA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.31 B
-$38.00 M-1.14%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly total expenses is $3.31 billion, with the most recent change of -$38.00 million (-1.14%) on December 31, 2024.
- Over the past year, TEVA quarterly total expenses has increased by +$132.00 million (+4.15%).
- TEVA quarterly total expenses is now -37.27% below its all-time high of $5.28 billion, reached on December 31, 2016.
Performance
TEVA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TEVA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.2% | +4.2% |
| 3 y3 years | +3.1% | +7.0% |
| 5 y5 years | -7.0% | -11.5% |
TEVA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.7% | -1.2% | +13.3% |
| 5 y | 5-year | -7.0% | +7.7% | -12.8% | +13.3% |
| alltime | all time | -26.2% | >+9999.0% | -37.3% | +1620.8% |
Teva Pharmaceutical Industries Limited Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $13.18 B(+4.2%) | $3.31 B(-1.1%) |
| Sep 2024 | - | $3.35 B(-0.0%) |
| Jun 2024 | - | $3.35 B(+5.4%) |
| Mar 2024 | - | $3.18 B(+0.2%) |
| Dec 2023 | $12.65 B(+3.4%) | $3.17 B(+2.4%) |
| Sep 2023 | - | $3.10 B(-4.2%) |
| Jun 2023 | - | $3.23 B(+2.5%) |
| Mar 2023 | - | $3.15 B(-2.9%) |
| Dec 2022 | $12.23 B(-4.3%) | $3.25 B(+11.2%) |
| Sep 2022 | - | $2.92 B(-5.6%) |
| Jun 2022 | - | $3.09 B(+4.0%) |
| Mar 2022 | - | $2.97 B(-9.2%) |
| Dec 2021 | $12.78 B(-6.0%) | $3.27 B(+3.1%) |
| Sep 2021 | - | $3.18 B(+2.5%) |
| Jun 2021 | - | $3.10 B(-4.0%) |
| Mar 2021 | - | $3.23 B(-13.6%) |
| Dec 2020 | $13.60 B(-4.0%) | $3.74 B(+14.7%) |
| Sep 2020 | - | $3.26 B(+2.4%) |
| Jun 2020 | - | $3.18 B(-6.9%) |
| Mar 2020 | - | $3.42 B(-9.9%) |
| Dec 2019 | $14.17 B(-8.0%) | $3.80 B(+12.7%) |
| Sep 2019 | - | $3.37 B(-4.1%) |
| Jun 2019 | - | $3.51 B(+0.7%) |
| Mar 2019 | - | $3.49 B(+1.4%) |
| Dec 2018 | $15.40 B(-13.8%) | $3.44 B(-11.1%) |
| Sep 2018 | - | $3.87 B(-2.1%) |
| Jun 2018 | - | $3.96 B(-4.3%) |
| Mar 2018 | - | $4.13 B(+4.9%) |
| Dec 2017 | $17.86 B(+3.2%) | $3.94 B(-16.4%) |
| Sep 2017 | - | $4.71 B(+1.6%) |
| Jun 2017 | - | $4.64 B(+1.6%) |
| Mar 2017 | - | $4.57 B(-13.4%) |
| Dec 2016 | $17.30 B(+18.0%) | $5.28 B(+12.8%) |
| Sep 2016 | - | $4.67 B(+23.1%) |
| Jun 2016 | - | $3.80 B(+7.0%) |
| Mar 2016 | - | $3.55 B(-6.7%) |
| Dec 2015 | $14.66 B(-7.1%) | $3.81 B(+8.5%) |
| Sep 2015 | - | $3.51 B(-3.5%) |
| Jun 2015 | - | $3.63 B(-1.9%) |
| Mar 2015 | - | $3.71 B(-7.0%) |
| Dec 2014 | $15.78 B(-3.5%) | $3.98 B(+2.0%) |
| Sep 2014 | - | $3.90 B(-1.2%) |
| Jun 2014 | - | $3.95 B(+0.2%) |
| Mar 2014 | - | $3.94 B(-10.3%) |
| Dec 2013 | $16.35 B(+1.3%) | $4.39 B(+8.7%) |
| Sep 2013 | - | $4.04 B(+1.9%) |
| Jun 2013 | - | $3.97 B(+0.7%) |
| Mar 2013 | - | $3.94 B(-7.9%) |
| Dec 2012 | $16.14 B(+12.8%) | $4.28 B(+9.7%) |
| Sep 2012 | - | $3.90 B(-0.8%) |
| Jun 2012 | - | $3.93 B(-2.3%) |
| Mar 2012 | - | $4.03 B(-10.9%) |
| Dec 2011 | $14.30 B(+20.8%) | $4.52 B(+38.6%) |
| Sep 2011 | - | $3.26 B(-2.5%) |
| Jun 2011 | - | $3.34 B(+5.0%) |
| Mar 2011 | - | $3.18 B(-4.1%) |
| Dec 2010 | $11.84 B(+9.3%) | $3.32 B(+10.4%) |
| Sep 2010 | - | $3.01 B(+10.6%) |
| Jun 2010 | - | $2.72 B(-2.2%) |
| Mar 2010 | - | $2.78 B(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $10.83 B(+10.4%) | $2.89 B(+7.1%) |
| Sep 2009 | - | $2.70 B(+2.0%) |
| Jun 2009 | - | $2.65 B(+2.0%) |
| Mar 2009 | - | $2.60 B(-26.8%) |
| Dec 2008 | $9.82 B(+40.0%) | $3.55 B(+61.8%) |
| Sep 2008 | - | $2.19 B(+0.3%) |
| Jun 2008 | - | $2.19 B(+15.4%) |
| Mar 2008 | - | $1.89 B(-1.1%) |
| Dec 2007 | $7.01 B(+11.1%) | $1.92 B(+11.7%) |
| Sep 2007 | - | $1.72 B(-1.9%) |
| Jun 2007 | - | $1.75 B(+7.0%) |
| Mar 2007 | - | $1.63 B(-11.9%) |
| Dec 2006 | $6.31 B(+60.3%) | $1.85 B(+18.7%) |
| Sep 2006 | - | $1.56 B(+4.3%) |
| Jun 2006 | - | $1.50 B(+9.5%) |
| Mar 2006 | - | $1.37 B(+31.4%) |
| Dec 2005 | $3.94 B(+8.7%) | $1.04 B(+3.5%) |
| Sep 2005 | - | $1.01 B(+9.4%) |
| Jun 2005 | - | $918.60 M(-5.7%) |
| Mar 2005 | - | $974.00 M(-1.3%) |
| Dec 2004 | $3.62 B(+51.5%) | $986.90 M(+6.2%) |
| Sep 2004 | - | $929.60 M(+5.7%) |
| Jun 2004 | - | $879.30 M(+6.2%) |
| Mar 2004 | - | $828.20 M(+15.8%) |
| Dec 2003 | $2.39 B(+19.9%) | $715.50 M(+16.2%) |
| Sep 2003 | - | $615.50 M(+27.6%) |
| Jun 2003 | - | $482.50 M(-16.5%) |
| Mar 2003 | - | $578.10 M(-1.6%) |
| Dec 2002 | $1.99 B(+17.3%) | $587.60 M(+15.3%) |
| Sep 2002 | - | $509.70 M(+10.7%) |
| Jun 2002 | - | $460.40 M(+5.4%) |
| Mar 2002 | - | $436.90 M(-4.0%) |
| Dec 2001 | $1.70 B(+23.7%) | $455.31 M(+12.0%) |
| Sep 2001 | - | $406.70 M(-4.7%) |
| Jun 2001 | - | $426.74 M(+3.6%) |
| Mar 2001 | - | $412.02 M(+20.3%) |
| Dec 2000 | $1.37 B(+35.4%) | $342.52 M(-8.8%) |
| Sep 2000 | - | $375.63 M(+0.1%) |
| Jun 2000 | - | $375.16 M(+33.3%) |
| Mar 2000 | - | $281.34 M(+12.6%) |
| Dec 1999 | $1.01 B(+11.3%) | $249.84 M(-7.3%) |
| Sep 1999 | - | $269.50 M(+8.2%) |
| Jun 1999 | - | $249.00 M(+0.9%) |
| Mar 1999 | - | $246.70 M(+28.3%) |
| Dec 1998 | $912.19 M(-3.3%) | $192.29 M(-27.1%) |
| Sep 1998 | - | $263.60 M(+17.9%) |
| Jun 1998 | - | $223.50 M(-4.1%) |
| Mar 1998 | - | $233.00 M |
| Dec 1997 | $943.10 M(+14.4%) | - |
| Dec 1996 | $824.50 M(+16.6%) | - |
| Dec 1995 | $707.10 M(+13.2%) | - |
| Dec 1994 | $624.80 M(+50.9%) | - |
| Dec 1993 | $414.00 M(+21.2%) | - |
| Dec 1992 | $341.60 M(+24.2%) | - |
| Dec 1991 | $275.00 M(-4.7%) | - |
| Dec 1990 | $288.70 M(+21.9%) | - |
| Dec 1989 | $236.90 M(+25.6%) | - |
| Dec 1988 | $188.60 M(+56.8%) | - |
| Mar 1987 | $120.30 M(+51.7%) | - |
| Mar 1986 | $79.30 M | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total expenses?
- What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total expenses?
- What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total expenses?
The current annual total expenses of TEVA is $13.18 B
What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total expenses is $17.86 B
What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
Over the past year, TEVA annual total expenses has changed by +$530.00 M (+4.19%)
What is Teva Pharmaceutical Industries Limited quarterly total expenses?
The current quarterly total expenses of TEVA is $3.31 B
What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total expenses is $5.28 B
What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?
Over the past year, TEVA quarterly total expenses has changed by +$132.00 M (+4.15%)